About this reference material
This preparation combines three synthetic compounds in a single vial: the copper tripeptide GHK-Cu, the pentadecapeptide BPC-157, and the thymosin beta-4 fragment TB-500. It is supplied under the abbreviation GLOW, which is a supply-market designation rather than a chemical name.
Blended preparations carry an additional documentation requirement. The quantity and purity of each component in the lot you receive are stated separately on its certificate of analysis. Note that copper complexes are light and moisture sensitive, which governs handling for the whole preparation.
Handling and storage
Supplied as a lyophilized powder in a sealed vial. Store sealed vials at -20°C, protected from light and moisture. Allow the vial to reach room temperature before opening. Reconstituted material should be held refrigerated, protected from light, and handled under the receiving laboratory’s own protocols.
Documentation
Each production lot is analyzed by an independent third-party laboratory before release. The purity and identity result for the lot you receive is stated on its certificate of analysis, which is published against the lot number printed on the vial label.
Research use only
This product is supplied strictly for in-vitro laboratory research use. It is not a medicine, is not approved by any medicines regulator, and is not for human or veterinary consumption, or for diagnostic, therapeutic, food, cosmetic or household use. Sale is restricted to persons aged 18 or over who are qualified researchers or who purchase on behalf of a research institution, laboratory or business. The purchaser is solely responsible for handling, storage, disposal and for compliance with all federal, state and local laws that apply to their own work.



